{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T04:01:57Z","timestamp":1790395317302,"version":"4.1.0"},"reference-count":20,"publisher":"Japanese Society of Internal Medicine","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Intern. Med."],"published-print":{"date-parts":[[2026]]},"DOI":"10.2169\/internalmedicine.8090-26","type":"journal-article","created":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T22:12:12Z","timestamp":1790028732000},"source":"Crossref","is-referenced-by-count":0,"title":["Prevalence and Impact of a Pathogenic <i>CYP27A1<\/i> Variant on the Phenotypes Among Patients with Monogenic Heterozygous Familial Hypercholesterolemia"],"prefix":"10.2169","author":[{"given":"Hayato","family":"Tada","sequence":"first","affiliation":[{"name":"Department of Cardiovascular Medicine, Kanazawa University Graduate School of Medical Sciences, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Atsushi","family":"Furukawa","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, Kanazawa University Graduate School of Medical Sciences, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masayuki","family":"Takamura","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, Kanazawa University Graduate School of Medical Sciences, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"962","reference":[{"key":"1","unstructured":"1. Goldstein JL, Hobbs HH, Brown MS. Familial hypercholesterolemia. In: The metabolic and molecular bases of inherited disease. Scriver CR, Beaudet AL, Sly WS, Valle D, Eds. McGraw-Hill, New York, 2001: 2863e913."},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Mabuchi H. Half a century tales of familial hypercholesterolemia (FH) in Japan. J Atheroscler Thromb 24: 189-207, 2017.","DOI":"10.5551\/jat.RV16008"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Tada H, Kawashiri MA, Nohara A, Inazu A, Mabuchi H, Yamagishi M. Impact of the clinical signs and genetic diagnosis of familial hypercholesterolemia on the prevalence of coronary artery disease in patients with severe hypercholesterolemia. Eur Heart J 38: 1573-1579, 2017.","DOI":"10.1093\/eurheartj\/ehx004"},{"key":"4","unstructured":"4. Sturm AC, Knowles JW, Gidding SS, et al. Clinical genetic testing for familial hypercholesterolemia: JACC scientific expert panel. J Am Coll Cardiol 72: 662-680, 2018."},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Tada H, Okada H, Nomura A, et al. Rare and deleterious mutations in ABCG5\/ABCG8 genes contribute to the mimicking and worsening of familial hypercholesterolemia phenotype. Circ J 83: 1917-1924, 2019.","DOI":"10.1253\/circj.CJ-19-0317"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Tada H, Yamagami K, Kojima N, et al. Prevalence and impact of apolipoprotein E7 on LDL cholesterol among patients with familial hypercholesterolemia. Front Cardiovasc Med 8: 625852, 2021.","DOI":"10.3389\/fcvm.2021.625852"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Koyama S, Sekijima Y, Ogura M, et al. Cerebrotendinous xanthomatosis: molecular pathogenesis, clinical spectrum, diagnosis, and disease-modifying treatments. J Atheroscler Thromb 28: 905-925, 2021.","DOI":"10.5551\/jat.RV17055"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Loh WJ, Watts GF. The inherited hypercholesterolemias. Endocrinol Metab Clin North Am 51: 511-537, 2022.","DOI":"10.1016\/j.ecl.2022.02.006"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Harada-Shiba M, Arai H, Ohmura H, et al. Guidelines for the diagnosis and treatment of adult familial hypercholesterolemia 2022. J Atheroscler Thromb 30: 558-586, 2023.","DOI":"10.5551\/jat.CR005"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Tada H, Kawashiri MA, Nomura A, et al. Oligogenic familial hypercholesterolemia, LDL cholesterol, and coronary artery disease. J Clin Lipidol 12: 1436-1444, 2018.","DOI":"10.1016\/j.jacl.2018.08.006"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Committee of the Japan Diabetes Society on the Diagnostic Criteria of Diabetes Mellitus, Seino Y, Nanjo K, et al. Report of the committee on the classification and diagnostic criteria of diabetes mellitus. J Diabetes Investig 1: 212-228, 2010.","DOI":"10.1111\/j.2040-1124.2010.00074.x"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. DeBarber AE, Duell PB. Update on cerebrotendinous xanthomatosis. Curr Opin Lipidol 32: 123-131, 2021.","DOI":"10.1097\/MOL.0000000000000740"},{"key":"13","unstructured":"13. Patni N, Wilson DP. Cerebrotendinous anthomatosis. In: Endotext. Feingold KR, Anawalt B, Blackman MR, et al., Eds. MDText.com, Inc., South Dartmouth (MA), 2000."},{"key":"14","unstructured":"14. Chen S, Francioli LC, Goodrich JK, et al. A genomic mutational constraint map using variations in 76,156 human genomes. Nature 625: 92-100, 2024."},{"key":"15","doi-asserted-by":"crossref","unstructured":"15. Appadurai V, DeBarber A, Chiang PW, et al. Apparent underdiagnosis of cerebrotendulous xanthomatosis revealed by analysis of ~60,000 human exomes. Mol Genet Metab 116: 298-304, 2015.","DOI":"10.1016\/j.ymgme.2015.10.010"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16. Pramparo T, Steiner RD, Rodems S, Jenkinson C. Allelic prevalence and geographic distribution of cerebrotendinous xanthomatosis. Orphanet J Rare Dis 18: 13, 2023.","DOI":"10.1186\/s13023-022-02578-1"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17. von Bahr S, Movin T, Papadogiannakis N, et al. Mechanism of accumulation of cholesterol and cholestanol in tendons and the role of sterol 27-hydroxylase (CYP27A1). Arterioscler Thromb Vasc Biol 22: 1129-1135, 2002.","DOI":"10.1161\/01.ATV.0000022600.61391.A5"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18. Inanloorahatloo K, Zand Parsa AF, Huse K, et al. Mutation in CYP27A1 identified in a family with coronary artery disease. Eur J Med Genet 56: 655-660, 2013.","DOI":"10.1016\/j.ejmg.2013.09.008"},{"key":"19","unstructured":"19. Schaefer EJ, Tsunoda F, Diffenderfer M, Polisecki E, Thai N, Asztalos B. Measurement of Lipids, Lipoproteins, Apolipoproteins, Fatty Acids, and Sterols, and Next-Generation Sequencing for the Diagnosis and Treatment of Lipid Disorders. In: Endotext. Feingold KR, Ahmed SF, Anawalt B, et al., Eds. MDText.com, Inc., South Dartmouth (MA), 2016."},{"key":"20","doi-asserted-by":"crossref","unstructured":"20. DeBarber AE, Schaefer EJ, Do J, et al. Genetically and clinically confirmed atypical cerebrotendulous xanthomatosis with normal cholestanol levels and marked elevations of bile acid precursors and bile alcohols. J Clin Lipidol 18: e465-e476, 2024.","DOI":"10.1016\/j.jacl.2024.03.004"}],"container-title":["Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/advpub\/0\/advpub_8090-26\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T03:33:06Z","timestamp":1790393586000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/advpub\/0\/advpub_8090-26\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026]]},"references-count":20,"URL":"https:\/\/doi.org\/10.2169\/internalmedicine.8090-26","relation":{},"ISSN":["0918-2918","1349-7235"],"issn-type":[{"value":"0918-2918","type":"print"},{"value":"1349-7235","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026]]},"article-number":"8090-26"}}